Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Oxcarbazepina para los episodios afectivos agudos en el trastorno bipolar

Información

DOI:
https://doi.org/10.1002/14651858.CD004857.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 07 diciembre 2011see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Trastornos mentales comunes

Copyright:
  1. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Akshya Vasudev

    Correspondencia a: University of Western Ontario, London Health Sciences Centre, Victoria Hospital, London, Canada

    [email protected]

    [email protected]

  • Karine Macritchie

    Division of Psychiatry, University of Edinburgh, Edinburgh, UK

  • Kamini Vasudev

    University of Western Ontario, London Health Sciences Centre, Victoria Hospital, London, Canada

  • Stuart Watson

    Department of Psychiatry, Leazes Wing, Royal Victoria Infirmary, Newcastle‐upon‐Tyne, UK

  • John Geddes

    Department of Psychiatry, University of Oxford/Warneford Hospital, Oxford, UK

  • Allan H Young

    Division of Experimental Medicine, Centre for Mental Health, Imperial College London, London, UK

Contributions of authors

Dr A Vasudev: performed literature search, data extractions, data analysis, selection of trials, co‐wrote the protocol and drafted the review
Dr KAN Macritchie: data extraction, selection of trials, co‐wrote the protocol and drafted the review
Dr K Vasudev: quality assessment, contributed to drafting of the review

Dr S Watson: quality assessment, data extraction, contributed to drafting of the review
Prof AH Young: quality assessment, commented on the protocol and contributed to drafting of the review
Prof JR Geddes: commented on the protocol and contributed to drafting of the review

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • Stanley Medical Research Institute, USA.

Declarations of interest

None of the reviewers is an employee of or has shares in a pharmaceutical company. JRG currently receives research funding from UK Medical Research Council, UK Economic and Social Research Council, the National Institute for Health Research, and the Stanley Medical Research Institute. He was expert witness for Dr Reddys Laboratories and is Chief Investigator on the CEQUEL trial to which GlaxoSmithKline have contributed and supplied investigational drugs and placebo.Professor AH Young, Dr S Watson, Dr A Vasudev and Dr K Macritchie have spoken at meetings and attended conferences sponsored by various pharmaceutical companies and have participated in trials sponsored by pharmaceutical companies. Dr Karine Macritchie has worked on a project supported by an award NS‐EU‐166 from the Translational Medicine Research Collaboration. This consortium comprises the Universities of Aberdeen, Dundee, Edinburgh and Glasgow, the four associated NHS Health Boards (Grampian, Tayside, Lothian and Greater Glasgow and Clyde), Scottish Enterprise and Pfizer (formerly Wyeth). She has also received funding for travel, accommodation and conference expenses from Astrazeneca.

Acknowledgements

The authors wish to gratefully acknowledge the help of CCDAN editorial staff with the review.

Version history

Published

Title

Stage

Authors

Version

2011 Dec 07

Oxcarbazepine for acute affective episodes in bipolar disorder

Review

Akshya Vasudev, Karine Macritchie, Kamini Vasudev, Stuart Watson, John Geddes, Allan H Young

https://doi.org/10.1002/14651858.CD004857.pub2

2003 Oct 20

Oxcarbazepine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability

Protocol

Akshya Vasudev, Karine Macritchie, Stuart Watson, John Geddes, Allan H Young

https://doi.org/10.1002/14651858.CD004857

Differences between protocol and review

The search strategy has been altered (December 2010) from that which appeared in the publication of the initial protocol (2004) on the advice of CCDAN Trials Search Co‐ordinator Sarah Dawson.

The Methods have been updated in line with the 2008 Cochrane Reviewers' Handbook, particularly as concerns 'Risk of bias' tables.